Compare AMPH & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | DAVA |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 356.2M |
| IPO Year | 2014 | 2018 |
| Metric | AMPH | DAVA |
|---|---|---|
| Price | $25.25 | $6.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $31.00 | $16.33 |
| AVG Volume (30 Days) | 368.5K | ★ 1.2M |
| Earning Date | 11-06-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.26 |
| EPS | ★ 2.27 | 0.25 |
| Revenue | $723,305,000.00 | ★ $1,015,391,026.00 |
| Revenue This Year | $1.35 | N/A |
| Revenue Next Year | $5.10 | $3.62 |
| P/E Ratio | ★ $11.14 | $25.92 |
| Revenue Growth | N/A | ★ 1.07 |
| 52 Week Low | $20.39 | $6.02 |
| 52 Week High | $45.39 | $34.94 |
| Indicator | AMPH | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 42.80 |
| Support Level | $25.22 | $6.02 |
| Resistance Level | $27.84 | $6.78 |
| Average True Range (ATR) | 0.80 | 0.27 |
| MACD | -0.22 | 0.14 |
| Stochastic Oscillator | 2.56 | 72.29 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.